1LyMwl4

68 REVISTA ARGENTINA DE CARDIOLOGÍA / VOL 83 SUPLEMENTO 2 / JUNIO 2015
BIBLIOGRAFÍA
1. Hauck AJ, Freeman DP, Ackermann DM, Danielson GK, Edwards
WD. Surgical pathology of the tricuspid valve: a study of 363 cases
spanning 25 years. Mayo Clin Proc 1988;63:851-63.
2. Essien IO, Onwubere BJ, Anisiuba BC, Ejim EC, Andy JJ, Ike
SO. One year echocardiographic study of rheumatic heart disease at
Enugu, Nigeria. Niger Postgrad Med J 2008;15:175-8.
3. Shah PM, Raney AA. Tricuspid valve disease. Curr Probl Cardiol
2008;33:47-84.
4. Daniels SJ, Mintz GS, Kotler MN. Rheumatic tricuspid valve
disease: two-dimensional echocardiographic, hemodynamic, and
angiographic correlations. Am J Cardiol 1983;51:492-6.
5. Anwar AM, Geleijnse ML, Soliman OI, McGhie JS, Nemes A, Ten
Cate FJ. Evaluation of rheumatic tricuspid valve stenosis by real-time
three-dimensional echocardiography. Heart 2007;93:363-4.
6. Badano LP, Agricola E, Perez de Isla L, Gianfagna P, Zamorano
JL. Evaluation of the tricuspid valve morphology and function by
transthoracic real-time three-dimensional echocardiography. Eur J
Echocardiogr 2009;10:477-84.
7. Muraru D, Badano LP, Sarais C, Soldà E, Iliceto S. Evaluation
of tricuspid valve morphology and function by transthoracic threedimensional
echocardiography. Curr Rep Cardiol 2011;13:242-9.
8. Ashraf T, Pathan A, KundiA. Percutaneous balloon valvuloplasty of
coexisting mitral and tricuspid stenosis: single-wire, double-balloon
technique. J Invasive Cardiol 2008;20:E126-8.
9. Sharma S, Loya YS, Desai DM, Pinto RJ. Percutaneous double
valve balloon valvotomy for multivalve stenosis: immediate results
and intermediate-term follow-up. Am Heart J 1997;133:64-70.
10. Sancaktar O, Kumbasar SD, Semiz E, Yalçinkaya S. Late results of
combined percutaneous balloon valvuloplasty of mitral and tricuspid
valves. Cathet Cardiovasc Diagn 1998;45:246-50.
11. Sahn D, Maciel B. Physiological valvular regurgitation. Doppler
echocardiography and the potential for iatrogenic heart disease.
Circulation 1988;78:1075-7.
12. Klein AL, Burstow DJ, Tajik AJ, Zachariah PK, TaliercioCP, Taylor
CL, et al. Age-related prevalence of valvular regurgitation in normal
subjects: a comprehensive color flow examination of 118 volunteers.
J Am Soc Echocardiogr 1990;3:54-63.
13. Zoghbi W, Enriquez-Sarano M, Foster E, Grayburn P, Kraft C,
Levine R. Recommendations for Evaluation of the Severity of Native
Valvular Regurgitation with Two-dimensional and Doppler Echocardiography.
J Am Soc Echocardiogr 2003;16:777-802.
14. Grossmann G, Stein M, Kochs M, Hoher M, Koenig W, Hombach
V, et al. Comparison of the proximal flow convergence method and
the jet area method for the assessment of the severity of tricuspid
regurgitation. Eur Heart J 1998;19:652-9.
15. García Fernandez MA, San Román D, Buhuo Zamora H. Insuficiencia
Tricuspídea. En: García Fernández MA. Principios y prácticas
de Doppler cardíaco. McGraw Hill Interamericana; 1995:161.
16. Chopra H, Nanda N, Fan P, Kapur K, Goyal R. Can two dimensional
echocardiography and Doppler color flow mappin identify the
need for tricuspid valve repair? J Am Coll Cardiol 1989;14:1266-72.
17. Tribouilloy CM, Enriquez-Sarano M, Bailey KR, Tajik AJ, Seward
JB. Quantification of tricuspid regurgitation by measuring the width
of the vena contracta with doppler color flow imaging: a clinical study.
J Am Coll Cardiol 2000;36:472-8.
18. Bernheim AM, Connolly HM, Pellikka PA. Carcinoid heart disease.
Curr Treat Options Cardiovasc Med 2007;9:482-9.
19. Bhattacharyya S, Davar J, Dreyfus G, Caplin ME. Carcinoid heart
disease. Circulation 2007;116:2860-5.
20. Delgado Ramis LJ, Montiel J, Arís J, Caralps JM. Rotura
traumática de la válvula tricúspide: presentación de tres casos. Rev
Esp Cardiol 2000;53:874-7.
21. van Son JA, Danielson GK, Schaff HV, Miller FA Jr. Traumatic
tricuspid valve insufficiency. Experience in thirteen patients. J Thorac
Cardiovasc Surg 1994;108:893-8.
22. Thekkudan J, Luckraz H, Ng A, Norell M. Tricuspid valve chordal
rupture due to airbag injury and review of pathophysiological mechanisms.
Interact Cardiovasc Thorac Surg 2012;15:555-7.
23. Kim JB, Spevack DM, Tunick PA, Bullinga JR, Kronzon I, Chinitz
LA, Reynolds HR. The effect of transvenous pacemaker and implantable
cardioverter defibrillator lead placement on tricuspid valve function:
an observational study. J Am Soc Echocardiogr 2008;21:284-7.
24. Carpentier A, Chauvaud S, Macé L, Relland J, Mihaileanu S,
Marino JP, Abry B, Guibourt P. A new reconstructive operation for
Ebstein’s anomaly of the tricuspid valve. J Thorac Cardiovasc Surg
1988;96:92-101.
25. Attenhofer Jost CH, Connolly HM, O’Leary PW, Warnes CA, Tajik
AJ, Seward JB. Left heart lesions in patients with Ebstein anomaly.
Mayo Clin Proc 2005;80:361-8.
26. Sarris GE, Giannopoulos NM, Tsoutsinos AJ, Chatzis AK, Kirvassilis
G, Brawn WJ, Comas JV, Corno AF, Di Carlo D, Fragata J,
Hraska V, Jacobs JP, Krupianko S, Sairanen H, Stellin G, Urban A,
Ziemer G; European Congenital Heart Surgeons Association. Results
of surgery for Ebstein anomaly: a multicenter study from the European
Congenital Heart Surgeons Association. J Thorac Cardiovasc
Surg 2006;132:50-7.
27. Taramasso M, Vanermen H, Maisano F, Guidotti G, La Canna
G, Alfieri O. The growing clinical importance of secondary tricuspid
regurgitation. J Am Coll Cardiol 2012;59:703-10.
28. Frater R. Tricuspid insufficiency. J Thorac Cardiovasc Surg
2001;122:427-9.
29. Haddad F, Doyle R, Murphy DJ, Hunt SA. Right ventricular
function in cardiovascular disease, Part II: Pathophysiology, clinical
importance, and management of right ventricular failure. Circulation
2008;117:1717-31.
30. Kiely DG, Cargill RI, Lipworth BJ. Angiotensin II receptor blockade
and effects on pulmonary hemodynamics and hypoxic pulmonary
vasoconstriction in humans. Chest 1996;110:698-703.
31. Maeder MT, Holst DP, Kaye DM. Tricuspid regurgitation contributes
to renal dysfunction in patients with heart failure. J Card
Fail 2008;14:824-30.
32. King RM, Schaff HV, Danielson GK, Gersh BJ, Orszulak TA,
Piehler JM, et al. Surgery for tricuspid regurgitation late after mitral
valve replacement. Circulation 1984;70(3 Pt 2):I193-7.
33. Matsunaga A, Duran CM. Progression of tricuspid regurgitation
after repaired functional ischemic mitral regurgitation. Circulation
2005;112(9 Suppl):I453-7.
34. Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation
on long-term survival. J Am Coll Cardiol 2004;43:405-9.
35. Di Mauro M, Bivona A, Iacò AL, Contini M, Gagliardi M, Varone
E, et al. Mitral valve surgery for functional mitral regurgitation:
prognostic role of tricuspid regurgitation. Eur J Cardiothorac Surg
2009;35:635-9.
36. Antunes MJ, Barlow JB. Management of tricuspid valve regurgitation.
Heart 2007;93:271-6.
37. Rogers JH, Bolling SF. The tricuspid valve: current perspective
and evolving management of tricuspid regurgitation. Circulation
2009;119:2718-25.
38. Dreyfus GD, Corbi PJ, Chan KM, Bahrami T. Secondary tricuspid
regurgitation or dilatation: which should be the criteria for surgical
repair? Ann Thorac Surg 2005;79:127-32.
39. Kim HK, Kim YJ, Park JS, Kim KH, Kim KB, Ahn H, et al. Determinants
of the severity of functional tricuspid regurgitation. Am
J Cardiol 2006;98:236-42.
40. Shiran A, Sagie A. Tricuspid regurgitation in mitral valve disease
incidence, prognostic implications, mechanism, and management. J
Am Coll Cardiol 2009;53:401-8.
41. Fukuda S, Song JM, Gillinov AM, McCarthy PM, Daimon M,
Kongsaerepong V, et al. Tricuspid valve tethering predicts residual
tricuspid regurgitation after tricuspid annuloplasty. Circulation
2005;111:975-9.
42. Porter A, Shapira Y, Wurzel M, Sulkes J, Vaturi M, Adler Y, et al.
Tricuspid regurgitation late after mitral valve replacement: clinical
and echocardiographic evaluation. J Heart Valve Dis 1999;8:57-62.